Guidelines International Network | Guidelines International Network (GIN)

Promoting 2SLGBTQI+ Health Equity

Guideline Contact: Nafsin Nizum (nnizum@rnao.ca)
Keywords: 2SLGBTQI+ Health Equity Diversity
Publication Date: 21-Jul
Publication Scope: assessment; implementation; screening; Social Considerations
Guideline Publication Status: Published
Languages: English
Authors: RNAO (CA)
Publication Year: 2021

MeSH Terms: Pediatrics (G02.403.776.610); Nursing (G02.478); Respiratory Tract Diseases (C08)
Guideline Contact: Katherine Wallace (kwallace@rnao.org)
Publication Scope: assessment; management; patient_education
Guideline Publication Status: Published
Languages: English; Spanish
Authors: RNAO (CA)
Publication Year: 2004

MeSH Terms: Physical Education and Training (I02.233.543); Physical Fitness (G11.427.685)
Publication Scope: prevention
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2009

MeSH Terms: Behavioral Disciplines and Activities (F04); Preventive Health Services (N02.421.726); Public Health (N06.850); Health Promotion (N02.421.726.507); Public Health Practice (N06.850.780)
Publication Scope: prevention
Countries of Application: United Kingdom
Guideline Publication Status: Published
Languages: English
Authors: NICE (UK)
Publication Year: 2008

MeSH Terms: Embolism and Thrombosis (C14.907.355)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Prevention of venous thromboembolism
Keywords: Thromboembolieprophylaxe, Thromboseprophylaxe, venöse Thromboembolie, Thrombose
Date for Review: 27/08/2025
Publication Scope: prevention
Countries of Application: Germany
Guideline Publication Status: Under Review
Languages: German
Authors: AWMF (DE)
Publication Year: 2015

MeSH Terms: Respiratory Syncytial Virus Infections (C02.782.580.600.620.750)
Guideline Contact: Ina Kopp (imwi@awmf.org)
English Title Translation: Prophylaxis of severe diseases by respiratory syncytial virus (RSV) in at-risk children
Keywords: Palivizumab, Respiratory Syncytial Virus (RSV), Frühgeborene, angeborene Herzfehler, Lungenschaden (des Frühgeborenen), Respiratory Syncytial Virus (RSV), preterm neonate, congenital heart defect, chronic lung disease (after premature birth)
Date for Review: 24/09/2028
Publication Date: 26/09/2023
Publication Scope: prevention
Countries of Application: Germany
Guideline Publication Status: Published
Languages: German
Authors: AWMF (DE)
Publication Year: 2023